>It's really really to early to say yes or no, and the fact that the article tries to make a claim either way, is worrying.
This is exactly what the phase 1 trial (the result which were just released) tries to establish -
>Phase I trials were formerly referred to as “first-in-man studies” but the field generally moved to the gender-neutral language phrase "first-in-humans" in the 1990s;[5] these trials are the first stage of testing in human subjects.[6] They are designed to test the safety, side effects, best dose, and formulation method for the drug.[7] Phase I trials are not randomized, and thus are vulnerable to selection bias.[8]
>It's really really to early to say yes or no, and the fact that the article tries to make a claim either way, is worrying.
This is exactly what the phase 1 trial (the result which were just released) tries to establish -
>Phase I trials were formerly referred to as “first-in-man studies” but the field generally moved to the gender-neutral language phrase "first-in-humans" in the 1990s;[5] these trials are the first stage of testing in human subjects.[6] They are designed to test the safety, side effects, best dose, and formulation method for the drug.[7] Phase I trials are not randomized, and thus are vulnerable to selection bias.[8]
https://en.m.wikipedia.org/wiki/Phases_of_clinical_research